Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Quercetin-4'-glucoside
1. 20229-56-5
2. Spiraein
3. Spiraeosid
4. Quercetin 4'-o-glucoside
5. Quercetin 4'-glucoside
6. Quercetin-4'-glucoside
7. Chembl402947
8. Chebi:75839
9. K2b74751xi
10. Quercetin 4'-o-beta-d-glucopyranoside
11. 3,5,7-trihydroxy-2-[3-hydroxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one
12. Spiraein (acacia)
13. Spireoside
14. Quercetin 4'-o-beta-d-glucoside
15. Einecs 243-614-6
16. Quercetin 4'-b-d-glucoside
17. Unii-k2b74751xi
18. 4h-1-benzopyran-4-one, 2-(4-(.beta.-d-glucopyranosyloxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-
19. 4h-1-benzopyran-4-one, 2-[4-(.beta.-d-glucopyranosyloxy)-3-hydroxyphenyl]-3,5,7-trihydroxy-
20. Spiraeoside [inci]
21. 2-(4-(beta-d-glucopyranosyloxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one
22. Spiraeoside [who-dd]
23. Spireoside (6ci,7ci,8ci)
24. Schembl1155660
25. Spiraeoside, Analytical Standard
26. Dtxsid00174078
27. Quercetin 4'-monoglucoside
28. Hy-n8253
29. Zinc4349687
30. Bdbm50362884
31. Mfcd00221723
32. 4h-1-benzopyran-4-one, 2-(4-(beta-d-glucopyranosyloxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-
33. Luteolin 4'-.beta.-d-glucoside
34. Ncgc00163625-01
35. Cs-0141978
36. Quercetin 4'-.beta.-d-glucopyranoside
37. D85150
38. 229s565
39. J-013135
40. Q7577713
41. Spiraeoside (constituent Of Hawthorn Leaf With Flower) [dsc]
42. 2-hydroxy-4-(3,5,7-trihydroxy-4-oxo-4h-chromen-2-yl)phenyl Beta-d-glucopyranoside
43. 3,5,7-trihydroxy-2-(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4h-chromen-4-one
| Molecular Weight | 464.4 g/mol |
|---|---|
| Molecular Formula | C21H20O12 |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 4 |
| Exact Mass | 464.09547607 g/mol |
| Monoisotopic Mass | 464.09547607 g/mol |
| Topological Polar Surface Area | 207 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 758 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Spiraeoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spiraeoside, including repackagers and relabelers. The FDA regulates Spiraeoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spiraeoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Spiraeoside supplier is an individual or a company that provides Spiraeoside active pharmaceutical ingredient (API) or Spiraeoside finished formulations upon request. The Spiraeoside suppliers may include Spiraeoside API manufacturers, exporters, distributors and traders.
Spiraeoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spiraeoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spiraeoside GMP manufacturer or Spiraeoside GMP API supplier for your needs.
A Spiraeoside CoA (Certificate of Analysis) is a formal document that attests to Spiraeoside's compliance with Spiraeoside specifications and serves as a tool for batch-level quality control.
Spiraeoside CoA mostly includes findings from lab analyses of a specific batch. For each Spiraeoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spiraeoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Spiraeoside EP), Spiraeoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spiraeoside USP).
LOOKING FOR A SUPPLIER?
